Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE

authors:

avatar Santosh kumar Gupta 1 , * , avatar Suhas Singla 1 , avatar Nishikant A Damle 1 , avatar Krishankant Agarwal 1 , avatar Chandersekhar Bal 1

Department of Nuclear Medicine, All India Institute of Medical Sciences, [email protected], India

how to cite: kumar Gupta S, Singla S, A Damle N, Agarwal K, Bal C. Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE. Int J Endocrinol Metab.10(4): 629-633. doi: 10.5812/ijem.4313.

Abstract

Abstract:

MEN-I is a rare genetic disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary gland, and pancreatic islet cells. We present a case of MEN-I syndrome diagnosed using predominantly nuclear medicine imaging followed by radionuclide therapy, thus emphasizing the role of nuclear imaging in diagnosing and treating MEN-I.

Full Text

Full text is available in PDF

© 2012, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.